» Articles » PMID: 22745672

µ-Calpain Conversion of Antiapoptotic Bfl-1 (BCL2A1) into a Prodeath Factor Reveals Two Distinct Alpha-helices Inducing Mitochondria-mediated Apoptosis

Overview
Journal PLoS One
Date 2012 Jun 30
PMID 22745672
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Anti-apoptotic Bfl-1 and pro-apoptotic Bax, two members of the Bcl-2 family sharing a similar structural fold, are classically viewed as antagonist regulators of apoptosis. However, both proteins were reported to be death inducers following cleavage by the cysteine protease µ-calpain. Here we demonstrate that calpain-mediated cleavage of full-length Bfl-1 induces the release of C-terminal membrane active α-helices that are responsible for its conversion into a pro-apoptotic factor. A careful comparison of the different membrane-active regions present in the Bfl-1 truncated fragments with homologous domains of Bax show that helix α5, but not α6, of Bfl-1 induces cell death and cytochrome c release from purified mitochondria through a Bax/Bak-dependent mechanism. In contrast, both helices α5 and α6 of Bax permeabilize mitochondria regardless of the presence of Bax or Bak. Moreover, we provide evidence that the α9 helix of Bfl-1 promotes cytochrome c release and apoptosis through a unique membrane-destabilizing action whereas Bax-α9 does not display such activities. Hence, despite a common 3D-structure, C-terminal toxic domains present on Bfl-1 and Bax function in a dissimilar manner to permeabilize mitochondria and induce apoptosis. These findings provide insights for designing therapeutic approaches that could exploit the cleavage of endogenous Bcl-2 family proteins or the use of Bfl-1/Bax-derived peptides to promote tumor cell clearance.

Citing Articles

STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma.

Xie B, Zhong B, Zhao Z, Hu J, Yang J, Xie Y Cancer Metab. 2023; 11(1):26.

PMID: 38111065 PMC: 10726618. DOI: 10.1186/s40170-023-00323-1.


MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.

Lu X, Li G, Liu S, Wang H, Chen B J Ovarian Res. 2021; 14(1):90.

PMID: 34238324 PMC: 8268593. DOI: 10.1186/s13048-021-00841-w.


Exploring the Conformational Space of Bcl-2 Protein Variants: Dynamic Contributions of the Flexible Loop Domain and Transmembrane Region.

Caro-Gomez L, Rosas-Trigueros J, Mixcoha E, Vique-Sanchez J, Gasperin-Sanchez H, Benitez-Cardoza C Molecules. 2019; 24(21).

PMID: 31671865 PMC: 6865210. DOI: 10.3390/molecules24213896.


The Incomplete Puzzle of the BCL2 Proteins.

Flores-Romero H, Garcia-Saez A Cells. 2019; 8(10).

PMID: 31569576 PMC: 6830314. DOI: 10.3390/cells8101176.


BFL1 modulates apoptosis at the membrane level through a bifunctional and multimodal mechanism showing key differences with BCLXL.

Flores-Romero H, Landeta O, Ugarte-Uribe B, Cosentino K, Garcia-Porras M, Garcia-Saez A Cell Death Differ. 2018; 26(10):1880-1894.

PMID: 30560933 PMC: 6748131. DOI: 10.1038/s41418-018-0258-5.


References
1.
Matsuyama S, Schendel S, Xie Z, Reed J . Cytoprotection by Bcl-2 requires the pore-forming alpha5 and alpha6 helices. J Biol Chem. 1998; 273(47):30995-1001. DOI: 10.1074/jbc.273.47.30995. View

2.
Adams J, Cory S . The Bcl-2 protein family: arbiters of cell survival. Science. 1998; 281(5381):1322-6. DOI: 10.1126/science.281.5381.1322. View

3.
Heimlich G, McKinnon A, Bernardo K, Brdiczka D, Reed J, Kain R . Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6. Biochem J. 2003; 378(Pt 1):247-55. PMC: 1223939. DOI: 10.1042/BJ20031152. View

4.
Schlesinger P, Gross A, Yin X, Yamamoto K, Saito M, Waksman G . Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc Natl Acad Sci U S A. 1997; 94(21):11357-62. PMC: 23466. DOI: 10.1073/pnas.94.21.11357. View

5.
Bechinger B, Lohner K . Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta. 2006; 1758(9):1529-39. DOI: 10.1016/j.bbamem.2006.07.001. View